EYWN fundamentals
BioMerieux financial statements, including revenue, expenses, profit, and loss
The total revenue of EYWN for the last semiannual is 1.90 B EUR, and it's 0.14% lower compared to the previous semiannual. The net income of H1 24 is 215.30 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM